Patent: Dual Function Proteins for Treating Metabolic Disorders

Authors
Publication date
4 April 2013
Publisher
eCommons

Abstract

The present invention relates to new proteins comprising fibroblast growth factor 2 1 (FGF21 ) and other metabolic regulators known to improve metabolic profiles in subjects to whom they are administered

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Dayton

    redirect
    oaioai:ecommons.udayton.edu:chm_f...
    Last time updated on 17/02/2020